Cardano wins £10bn mandate from pharma giant

Consultant has wrested an advisory contract worth over £10 billion of GlaxoSmithKline assets from Aon Hewitt

Pharmaceuticals company GlaxoSmithKline has appointed Cardano as investment adviser to assets worth £10 billion owned by its final salary pension scheme.

Cardano, an Anglo-Dutch investment consultant, is taking over the contract from Aon Hewitt, which confirmed the loss, although it added that it had retained some actuarial work.

WSJ Logo
Venture Debt Firms Tilt Toward Mature CompaniesExternal link

Venture Debt Firms Tilt Toward Mature Companies